The Venture Codex Logo

The Venture Codex

Overview

Pharmaceutical company manufacturing and marketing ethical drugs.

Founded

1932

Deals ยท 12mo

0

Stage focus

Series C

Geographic focus

Japan

Sector focus

Biotechnology
Health Care
Manufacturing
Pharmaceutical

Investment portfolio

2rounds
NAMEDATESIZE
Frontier Field
Jul 2023Participated
$27 MSeries C
Ubie
Aug 2022Participated
$26 MSeries C
Frontier Field
Jul 2023Participated
$27 MSeries C
Ubie
Aug 2022Participated
$26 MSeries C
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

SUZUKEN: 2 funding rounds are recorded in the selected participation categories.All available history.
SUZUKEN: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series C+02

Monthly Deal Activity

SUZUKEN: 2 deals are recorded across 51 months.All available history.
SUZUKEN: 2 deals are recorded across 51 months. All available history
MonthDeals
Aug '221
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '231
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

SUZUKEN: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

SUZUKEN: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2
AI & Machine Learning2
Enterprise Software1
Data, Analytics & IT1

Deal Size Distribution

SUZUKEN: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

SUZUKEN: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M2
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

SUZUKEN: Japan has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

SUZUKEN: Japan has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
Japan2
SUZUKEN: 7 co-investors are shown, with Dai-ichi Life sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

SUZUKEN: 7 co-investors are shown, with Dai-ichi Life sharing 1 recorded deals. All available history
Co-investorShared deals
Dai-ichi Life1
Egg FORWARD1
NCB Venture Capital1
Norinchukin Capital1
PARAMOUNT BED1
Venture Capital Limited1
Yamanashi Chugin Management Consulting1

Investment Strategy

SUZUKEN: Led accounts for 0% and participating for 100% of round participation.All available history.
SUZUKEN: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating2100%
SUZUKEN: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
SUZUKEN: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Hiromi Miyata

President and Executive Officer

Masao Saito

Senior Executive Officer

Shigeru Asano

Executive Vice President

Yoshiki Bessho

Chairman and Executive Officer